• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 200533 Product 005 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N200533 005 6071970 Jun 6, 2017 U - 1178
N200533 005 6071970 Jun 6, 2017 U - 1276
N200533 005 7994364 Jun 27, 2025 Y Y U - 1178
N200533 005 7994364 Jun 27, 2025 Y Y U - 1276
N200533 005 8075872 Nov 20, 2023 Y
N200533 005 8114383 Oct 10, 2024 Y Y
N200533 005 8309060 Nov 20, 2023 Y U - 1178
N200533 005 8309060 Nov 20, 2023 Y U - 1276
N200533 005 8420056 Nov 20, 2023 Y
N200533 005 8536130 Sep 22, 2028 U - 1276
N200533 005 RE39593 Aug 5, 2022 Y Y U - 1178
N200533 005 RE39593 Aug 5, 2022 Y Y U - 1276

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N200533 005 I - 656 Aug 28, 2015
N200533 005 NCE Nov 20, 2013
N200533 005 NDF Aug 25, 2014


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through August 2014
Patent and Generic Drug Product Data Last Updated October 01, 2014

-
-